Oxford BioMedica (GB:OXB) has released an update.
Oxford BioMedica PLC has announced the appointment of Laurence Espinasse as a Non-Executive Director, tapping into her extensive legal and healthcare sector experience. Espinasse joins following Institut Mérieux’s acquisition of a significant stake in the company, reflecting strong confidence in Oxford BioMedica’s growth potential in the cell and gene therapy market. The company is poised to leverage her expertise to bolster its commercial momentum and leadership in the cell and gene therapy CDMO space.
For further insights into GB:OXB stock, check out TipRanks’ Stock Analysis page.
